Post Profile

Safety data support human testing of hematopoietic stem cell gene therapy for mucopolysaccharid I

(Mary Ann Liebert, Inc./Genetic Engineering News) Extensive biosafety studies of hematopoietic stem cell (HSC) gene therapy, intended to replace a protein that patients with the inherited disease mucopolysaccaridosis I (MPS I) cannot produce, support clinical testing of the stem cell-based gene addition approach in MPS I patients.
read more


Related Posts

UCLA Stem Cell Gene Therapy for Sickle Cell Disease Advances Toward Clinical Trials

Health : Newswise Medical News

UCLA Researchers have successfully established the foundation for using hematopoietic (blood-producing) stem cells from the bone marrow of patients with sickle cell disease to treat the disease.

Engineered protein combining those active in HIV and Moloney murine leukaemia virus opens door for safer gene therapy?

Health : Medical News Today

Gene therapy involves inserting healthy genetic material into a diseased cell. Using a carrier derived from a retrovirus, the genetic material is smuggled into a human cell where, once inside, it integrates itself into the cell's DN...

Autologous HSC Transplant May Treat Sickle Cell Disease

Health : Medical News Today

Sickle cell disease (SCD) is an autosomal recessive disorder caused by mutations in hemoglobin (HBB) that deform red blood cells. A small number of patients have been successfully treated with allogeneic hematopoietic stem cell (HSC...

Human Gene Therapy Expands With Robust New Methods Journal Dedicated To Technological Advances In Gene Therapy

Health : Medical News Today

Mary Ann Liebert, Inc. announces the launch of a journal expansion, Human Gene Therapy Methods, to complement the flagship publication Human Gene Therapy. HGT Methods, which is officially Part B of Human Gene Therapy, is dedicated t...

Stem cell gene therapy used to treat a fatal genetic brain disease in mice for the first time

Health : Medical News Today

Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time. The method was used to treat Sanfilippo - a fatal inherited condition which causes prog...


Copyright © 2016 Regator, LLC